怀孕期间母亲的信念和喘药物的坚持
Kelly Colas1, Jennifer Namazy2, Diana Johnson3
1Division of Allergy and Infectious Diseases, University of Washington, Seattle, Wash.
怀孕期间关于喘药物的安全性和有效性的担忧与不坚持有关. 在怀孕期间最佳控制喘对于母亲和婴儿的健康至关重要.
科学领域:
- 产科和妇科 产科和妇科
- 肺部病理学 肺部病理学
- 围产儿医学 围产儿医学
背景情况:
- 怀孕期间控制不良的喘会给母亲和婴儿带来风险.
- 在孕妇中,喘药物不服药是很常见的.
研究的目的:
- 调查与怀孕期间不服用喘药物相关的母亲的信仰,特征和婴儿出生结果.
主要方法:
- 在341名怀孕的喘妇女 (2014-2022) 的调查中,评估了喘药物的坚持.
- 统计分析 (t 测试,奇方,费舍尔精确,逻辑回归) 比较了坚持的群体.
- 分析了母亲的特征,信仰和婴儿出生结果.
主要成果:
- 11.7%的参与者报告了较低的喘药物坚持.
- 不遵守与相信喘药物在怀孕期间不安全或无效的信念相关.
- 在不坚持和早产之间没有发现有意义的关联,对于妊娠年龄的结果来说也很小.
结论:
- 关于喘药物的安全性和有效性的母亲的担忧与坚持有显著的关联.
- 解决这些问题可能会改善孕妇的喘管理.
更多相关视频
05:56A Traditional Chinese Medicine Characteristic Therapy for Bronchial Asthma: Moxibustion
Published on: May 12, 2023
06:39Using a Murine Model of Psychosocial Stress in Pregnancy as a Translationally Relevant Paradigm for Psychiatric Disorders in Mothers and Infants
Published on: June 13, 2021
相关概念视频
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
Asthma-I: Introduction
Asthma-IV: Nursing Management
First, in...
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Antiasthma Drugs: β2-Adrenoceptor Agonists
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
